LY573636

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Advanced Solid TumorsSolid Tumors

Phase 1

A Phase 1 Study in Patients With Solid Tumors

CompletedNCT01215916

Eli Lilly and CompanySolid Tumors

Start: 2008-02-29End: 2011-12-31Updated: 2019-03-15

A Safety Study in Participants With Advanced Solid Tumors

TerminatedNCT01284335

Eli Lilly and CompanyAdvanced Solid Tumors

Start: 2008-07-31End: 2016-05-31Updated: 2019-01-10